Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy

Nanomedicines have shown great potential in cancer therapy; in particular, the combination of chemotherapy and immunotherapy (namely chemoimmunotherapy) that is revolutionizing cancer treatment. Currently, most nanomedicines for chemoimmunotherapy are still in preclinical and clinical trials. Lipid-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tianqi, Suita, Yusuke, Miriyala, Saradha, Dean, Jordan, Tapinos, Nikos, Shen, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069739/
https://www.ncbi.nlm.nih.gov/pubmed/33918635
http://dx.doi.org/10.3390/pharmaceutics13040520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069739/
https://www.ncbi.nlm.nih.gov/pubmed/33918635
http://dx.doi.org/10.3390/pharmaceutics13040520

Ejemplares similares